位置:首页 > 蛋白库 > VP3_ROTHU
VP3_ROTHU
ID   VP3_ROTHU               Reviewed;         835 AA.
AC   Q91HJ9; D3G8E5;
DT   14-APR-2009, integrated into UniProtKB/Swiss-Prot.
DT   23-MAY-2018, sequence version 2.
DT   23-FEB-2022, entry version 49.
DE   RecName: Full=Protein VP3 {ECO:0000255|HAMAP-Rule:MF_04128};
DE   Includes:
DE     RecName: Full=2',5'-phosphodiesterase {ECO:0000255|HAMAP-Rule:MF_04128};
DE              EC=3.1.4.- {ECO:0000255|HAMAP-Rule:MF_04128};
DE   Includes:
DE     RecName: Full=mRNA guanylyltransferase {ECO:0000255|HAMAP-Rule:MF_04128};
DE              EC=2.7.7.50 {ECO:0000255|HAMAP-Rule:MF_04128};
DE   Includes:
DE     RecName: Full=mRNA (guanine-N(7))-methyltransferase {ECO:0000255|HAMAP-Rule:MF_04128};
DE              EC=2.1.1.56 {ECO:0000255|HAMAP-Rule:MF_04128};
OS   Rotavirus A (isolate RVA/Human/India/116E/1986/G9P8[11]) (RV-A).
OC   Viruses; Riboviria; Orthornavirae; Duplornaviricota; Resentoviricetes;
OC   Reovirales; Reoviridae; Sedoreovirinae; Rotavirus; Rotavirus A.
OX   NCBI_TaxID=638299;
OH   NCBI_TaxID=9606; Homo sapiens (Human).
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=20580391; DOI=10.1016/j.virol.2010.06.005;
RA   Rippinger C.M., Patton J.T., McDonald S.M.;
RT   "Complete genome sequence analysis of candidate human rotavirus vaccine
RT   strains RV3 and 116E.";
RL   Virology 405:201-213(2010).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC RNA] OF 5-295.
RX   PubMed=16972027; DOI=10.1007/s11262-005-0049-1;
RA   Subodh S., Bhan M.K., Ray P.;
RT   "Genetic characterization of VP3 gene of group A rotaviruses.";
RL   Virus Genes 33:143-145(2006).
CC   -!- FUNCTION: Multifunctional enzyme involved in mRNA capping. Catalyzes
CC       the formation of the 5' cap structure on the viral plus-strand
CC       transcripts. Specifically binds to GTP and displays guanylyltransferase
CC       and methyltransferase activities. Has affinity for ssRNA but not for
CC       dsRNA. Capping activity is non-specific and caps RNAs that initiate
CC       with either a G or an A residue. Together with VP1 polymerase, forms a
CC       VP1-VP3 complex positioned near the channels situated at each of the
CC       five-fold vertices of the core. Following infection, the outermost
CC       layer of the virus is lost, leaving a double-layered particle (DLP)
CC       made up of the core and VP6 shell. VP1 then catalyzes the transcription
CC       of fully conservative plus-strand genomic RNAs that are capped by VP3
CC       and extruded through the DLP's channels into the cytoplasm where they
CC       function as mRNAs for translation of viral proteins. DLPs probably have
CC       an RNA triphosphatase activity as well, whereas open cores do not.
CC       {ECO:0000255|HAMAP-Rule:MF_04128}.
CC   -!- FUNCTION: Counteracts the host innate immune response thanks to its
CC       phosphodiesterase that degrades the 5'-triphosphorylated, 2'-5' linked
CC       adenylate oligomers produced by the host cell IFN-inducible 2',5'-
CC       oligoadenylate synthetase (OAS). The host RNaseL is therefore not
CC       activated. {ECO:0000255|HAMAP-Rule:MF_04128}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a 5'-end diphospho-ribonucleoside in mRNA + GTP + H(+) = a 5'-
CC         end (5'-triphosphoguanosine)-(ribonucleoside) in mRNA + diphosphate;
CC         Xref=Rhea:RHEA:67012, Rhea:RHEA-COMP:17165, Rhea:RHEA-COMP:17166,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:33019, ChEBI:CHEBI:37565,
CC         ChEBI:CHEBI:167616, ChEBI:CHEBI:167617; EC=2.7.7.50;
CC         Evidence={ECO:0000255|HAMAP-Rule:MF_04128};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a 5'-end (5'-triphosphoguanosine)-(ribonucleoside) in mRNA +
CC         S-adenosyl-L-methionine = a 5'-end (N(7)-methyl 5'-
CC         triphosphoguanosine)-ribonucleoside in mRNA + S-adenosyl-L-
CC         homocysteine; Xref=Rhea:RHEA:67008, Rhea:RHEA-COMP:17166, Rhea:RHEA-
CC         COMP:17167, ChEBI:CHEBI:57856, ChEBI:CHEBI:59789, ChEBI:CHEBI:156461,
CC         ChEBI:CHEBI:167617; EC=2.1.1.56; Evidence={ECO:0000255|HAMAP-
CC         Rule:MF_04128};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=5'-triphosphoadenylyl-(2'->5')-adenylyl-(2'->5')-adenosine + 2
CC         H2O = 2 AMP + ATP + 2 H(+); Xref=Rhea:RHEA:45964, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:30616, ChEBI:CHEBI:67143,
CC         ChEBI:CHEBI:456215; Evidence={ECO:0000255|HAMAP-Rule:MF_04128};
CC   -!- SUBUNIT: Interacts with VP1. Interacts with VP2. {ECO:0000255|HAMAP-
CC       Rule:MF_04128}.
CC   -!- SUBCELLULAR LOCATION: Virion {ECO:0000255|HAMAP-Rule:MF_04128}.
CC       Note=Attached inside the inner capsid as a minor component. There are
CC       about 11 to 12 copies per virion. {ECO:0000255|HAMAP-Rule:MF_04128}.
CC   -!- DOMAIN: Contains a bipartite N7-methyltransferase domain, a 2'-O-
CC       methyltransferase domain and a GTase/RTPase domain. The C-terminus
CC       contains a phosphodiesterase domain that degrades the 5'-
CC       triphosphorylated, 2'-5' linked adenylate oligomers produced by the
CC       host cell in response to IFN stimulation. {ECO:0000255|HAMAP-
CC       Rule:MF_04128}.
CC   -!- SIMILARITY: Belongs to the rotavirus VP3 family. {ECO:0000255|HAMAP-
CC       Rule:MF_04128}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AY028978; AAK57549.1; -; Genomic_RNA.
DR   EMBL; FJ361203; ACO87888.1; -; Genomic_RNA.
DR   SMR; Q91HJ9; -.
DR   PRIDE; Q91HJ9; -.
DR   Proteomes; UP000137796; Genome.
DR   GO; GO:0019013; C:viral nucleocapsid; IEA:UniProtKB-UniRule.
DR   GO; GO:0005525; F:GTP binding; IEA:UniProtKB-UniRule.
DR   GO; GO:0016787; F:hydrolase activity; IEA:UniProtKB-KW.
DR   GO; GO:0004482; F:mRNA (guanine-N7-)-methyltransferase activity; IEA:UniProtKB-UniRule.
DR   GO; GO:0004484; F:mRNA guanylyltransferase activity; IEA:UniProtKB-UniRule.
DR   GO; GO:0003723; F:RNA binding; IEA:UniProtKB-UniRule.
DR   GO; GO:0039503; P:suppression by virus of host innate immune response; IEA:UniProtKB-KW.
DR   CDD; cd20757; capping_2-OMTase_Rotavirus; 1.
DR   HAMAP; MF_04124; Rota_VP3; 1.
DR   HAMAP; MF_04128; Rota_VP3_A; 1.
DR   InterPro; IPR011181; VP3_Rotav.
DR   Pfam; PF06929; Rotavirus_VP3; 1.
DR   PIRSF; PIRSF004015; LigT_rotavirus; 1.
DR   PROSITE; PS51589; SAM_MT56_VP3; 1.
PE   3: Inferred from homology;
KW   GTP-binding; Host-virus interaction; Hydrolase;
KW   Inhibition of host innate immune response by virus; Methyltransferase;
KW   mRNA capping; mRNA processing; Multifunctional enzyme; Nucleotide-binding;
KW   Nucleotidyltransferase; RNA-binding; S-adenosyl-L-methionine; Transferase;
KW   Viral immunoevasion; Virion.
FT   CHAIN           1..835
FT                   /note="Protein VP3"
FT                   /id="PRO_0000368068"
FT   REGION          171..245
FT                   /note="N7-methyltransferase activity"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_04128"
FT   REGION          246..428
FT                   /note="2'-O-methyltransferase activity"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_04128"
FT   REGION          429..555
FT                   /note="N7-methyltransferase activity"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_04128"
FT   REGION          556..692
FT                   /note="GTase/RTPase activity"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_04128"
FT   REGION          693..835
FT                   /note="2'-5'-phosphodiesterase activity"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_04128"
FT   ACT_SITE        718
FT                   /note="For 2'-5'-phosphodiesterase activity"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_04128"
FT   ACT_SITE        720
FT                   /note="For 2'-5'-phosphodiesterase activity"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_04128"
FT   ACT_SITE        797
FT                   /note="For 2'-5'-phosphodiesterase activity"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_04128"
FT   ACT_SITE        799
FT                   /note="For 2'-5'-phosphodiesterase activity"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_04128"
FT   CONFLICT        21..22
FT                   /note="VH -> DT (in Ref. 2; AAK57549)"
FT   CONFLICT        150
FT                   /note="D -> V (in Ref. 2; AAK57549)"
FT   CONFLICT        205
FT                   /note="K -> R (in Ref. 2; AAK57549)"
FT   CONFLICT        220
FT                   /note="L -> I (in Ref. 2; AAK57549)"
FT   CONFLICT        238
FT                   /note="T -> S (in Ref. 2; AAK57549)"
FT   CONFLICT        279
FT                   /note="K -> F (in Ref. 2; AAK57549)"
FT   CONFLICT        295
FT                   /note="D -> N (in Ref. 2; AAK57549)"
SQ   SEQUENCE   835 AA;  97962 MW;  6FA45B94B3B0B37D CRC64;
     MKVLALRHSV AQVYADTQTY VHDDSKDEYE NAFLISNLTT HNILYLNYSV KTLKILNKSG
     IAAIEIQSPD ELFTLIRCNF TYNYENNTVY LHDYSYYTNN EIRTDQHWVT KTDITNYLLP
     GWKLTYVGYN GKNTRGHYKF SFICQNAATD DDIIIEYIYS NELDFQTFLL RKIKERMTTS
     LPITRLSNRV FRDKLFSSIL NTHKKVINVG PRNESMFTFL NLPTIKQFSN GAYLVKHTIK
     LKQERWLGKR VSQFDIGQYK NMLNVITTIY YYYNLHFSKP IIYMLGSAPS YWIYDIKQYS
     DFTFETWDPL DTPYSTTHHK ELFFDKDINR LKDNSILYID IRTDRGNMDW KEWRKVVEHQ
     TISNLNIAYK YLSTGKAKVC CVKLTAMDLE LPVTTKLLHH PTTEVRSEFY AILDVWDVNT
     IKRFVPKGVF YAFINNVITE NVFIQPPFKL KTSSNDYIVA LYALSNDFNS RQDVINLINQ
     QKQSLITVRM NNTFRDEPKV NFKNIYDWTF LPTDFETKGS IITSYDGCLG IFGLSISLSS
     KPTGNNHLFI INGTDKYYKL DQYANHMGIS RRSHQIRFSE SATSYSGYIF RDLSNNNFNL
     IGTNVENSVS GHVYNALIYY RYNYAFDLKR WIYLHSIGKA NVEGGRYYEH APIELIYACR
     SAKEFAILQD DLTVLRYANE IERYINIVYN ITYADDPNYF IGIEFTNIPY EYDVKVPHLT
     LGVLFISDNM INDVITVLKK MKPELFKMEI STSYTYMLSD NIYVANASGV LSTYFKLYNM
     FYRSHITFGQ SRMFIPHITL SFSNRQMVRI ESTRLKISSI YLRKIKGETV FDMSE
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024